Please login to the form below

Not currently logged in
Email:
Password:

Rapivab

This page shows the latest Rapivab news and features for those working in and with pharma, biotech and healthcare.

BioCryst gets FDA nod for first intravenous flu drug

BioCryst gets FDA nod for first intravenous flu drug

The FDA gave the go-ahead yesterday for Rapivab (peramivir) to treat flu in adults who have been symptomatic for no more than two days, suggesting that regulatory compliance issues at ... Edward Cox, director of the Office of Antimicrobial Products at

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals in June 2015 Pharma deals in June 2015

    85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics